NCT06872840View on ClinicalTrials.gov

Adapting The Fear Of Recurrence Therapy (FORT) for Parents and Establishing Acceptability and Feasibility

NARecruitingINTERVENTIONAL
Enrollment

36

Participants

Timeline

Start Date

August 26, 2025

Primary Completion Date

August 26, 2026

Study Completion Date

May 26, 2027

Conditions
CancerParentFear of Cancer RecurrenceCBTChildhood Cancer Survivors
Interventions
BEHAVIORAL

Parent Fear of Recurrence Therapy (Parent-FORT)

7 weekly sessions of 120 minutes each. During the 7 weeks, participants will be asked to participate in activities, participate in group discussions, and complete homework assignments.

Trial Locations (1)

K1N6N5

RECRUITING

University of Ottawa, Ottawa

All Listed Sponsors
collaborator

Children's Hospital of Eastern Ontario

OTHER

collaborator

Alberta Children's Hospital

OTHER

lead

University of Ottawa

OTHER

NCT06872840 - Adapting The Fear Of Recurrence Therapy (FORT) for Parents and Establishing Acceptability and Feasibility | Biotech Hunter | Biotech Hunter